🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Split 2:1 del 22/11/1999

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.656.089

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
27,17 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 3 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
16/08/2011 0,2800 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/01/2009 59,10 59,79 57,62 57,78 -2,50% 3,67% 6.150.700
08/01/2009 58,06 59,28 58,02 59,26 +1,82% 2,17% 5.576.700
07/01/2009 57,83 58,75 57,74 58,20 -0,24% 1,75% 5.725.400
06/01/2009 60,04 60,15 57,75 58,34 -2,20% 4,00% 8.974.000
05/01/2009 59,22 59,65 58,00 59,65 +1,12% 2,79% 10.940.100
02/01/2009 58,59 59,08 57,75 58,99 +2,15% 2,27% 6.547.900
31/12/2008 57,11 58,22 57,06 57,75 +0,28% 2,03% 6.287.200
30/12/2008 57,00 57,66 56,82 57,59 +1,27% 1,47% 4.300.800
29/12/2008 57,36 57,56 56,27 56,87 -0,85% 2,25% 5.236.600
26/12/2008 57,25 57,80 56,91 57,36 +0,35% 1,55% 1.544.900
24/12/2008 57,38 57,89 56,88 57,16 -0,37% 1,76% 1.821.400
23/12/2008 57,56 58,66 57,15 57,37 +0,42% 2,62% 4.871.000
22/12/2008 58,17 58,52 56,48 57,13 -1,21% 3,51% 5.916.800
19/12/2008 58,11 59,27 57,52 57,83 -0,33% 3,01% 12.657.100
18/12/2008 58,60 60,00 57,53 58,02 -0,68% 4,22% 11.512.900
17/12/2008 58,99 59,52 58,41 58,42 -1,62% 1,88% 6.011.400
16/12/2008 57,89 59,50 57,84 59,38 +2,89% 2,87% 8.884.700
15/12/2008 57,78 58,49 57,44 57,71 -0,72% 1,82% 5.548.100
12/12/2008 56,06 58,34 56,05 58,13 +1,54% 4,08% 7.296.500
11/12/2008 58,01 58,83 56,90 57,25 -1,38% 3,33% 9.404.400
10/12/2008 58,13 58,25 57,00 58,05 +0,16% 2,15% 9.095.500
09/12/2008 57,95 58,25 56,97 57,96 -0,36% 2,21% 10.138.400
08/12/2008 57,94 58,64 56,84 58,17 +1,34% 3,11% 11.039.700
05/12/2008 56,03 57,94 55,42 57,40 +1,88% 4,50% 9.267.800
04/12/2008 56,80 57,59 56,00 56,34 -1,97% 2,80% 8.211.400
03/12/2008 53,60 57,74 53,50 57,47 +5,18% 7,91% 9.872.500
02/12/2008 54,86 55,80 53,66 54,64 -0,24% 3,90% 10.799.200
01/12/2008 54,94 56,58 54,42 54,77 -1,39% 3,93% 10.672.900
28/11/2008 55,41 55,99 55,10 55,54 -0,64% 1,61% 2.502.500
26/11/2008 54,13 55,90 54,12 55,90 +1,77% 3,29% 6.790.800